The Study of Abatacept in Combination With Etanercept

• Status: Completed
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Abatacept; Etanercept

Criteria

Inclusion Criteria:

• All subjects who had completed the short term portion of IM101-101.